Rave Restaurant Group Azioni (NASDAQ: RAVE)

Ultime notizie per Rave Restaurant Group (NASDAQ:RAVE) Azioni

Rave Restaurant Gr

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The company-owned restaurant segment includes sales and operating results for all company-owned restaurants. The Pizza Inn Franchising segment accounts for the company's revenue. Geographically, it generates the majority of the revenue from the United States.

&nbsp;Steakholder Foods Ltd. (Nasdaq: STKH), a global leader in 3D-printing technology for structured alt-protein production, announced today that it has received a positive Written Opinion from the International Searching Authority (ISA) regarding its international patent application PCT/US 24/34252. The application covers the printing system of the company's HD144 printer for plant-based fish, which is based on its proprietary DLS&#xAE; (Drop Location in Space) drop-on-demand printing technology.
The ISA determined that all 21 claims in the application fulfill the requirements of novelty, inventive step, and industrial applicability, confirming the uniqueness and innovation of Steakholder's system.
The patented system includes an advanced multi-component architecture for managing and delivering bio-ink materials, gas pressure control, and a central processing module that synchronizes the printer's operation. This system lies at the heart of the HD144 printer, purpose-built to produce high-fidelity, structured plant-based fish products.
DLS&#xAE;, Steakholder's drop-on-demand technology, enables ultra-precise deposition of micro-droplets of plant-based materials. This allows for accurate structuring and marbling that replicates the texture, layering, and appearance of conventional fish—unlocking new levels of realism in plant-based seafood.
"This positive opinion from the ISA is a meaningful milestone that reinforces the strength of our IP and the disruptive nature of our technology," said Arik Kaufman, CEO of Steakholder Foods. "Our DLS&#xAE;-based HD144 printer is raising the bar in plant-based seafood production, and this patent supports our global commercialization and strategic partnership goals."
The positive report positions Steakholder Foods to confidently pursue national phase filings in key global markets and fortify its leadership in the 3D-printed alternative protein sector.

News

STKH

Steakholder Foods Announces It Has Receives Positive Written Opinion From The International Searching Authority For A Patent Covering Its HD144 Fish Printer's DLS-Based DropOon-Demand Printing System

<ul>
<li>Offering consists of a common equity PIPE delivering $500M in gross proceeds ($400M in cash and $100M in Crypto), plus up to $750M in cash which may be received from exercised warrants to be issued in the private placement (assuming 100% of warrants are exercised).</li>
<li>The proceeds of the offering by CEA Industries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VAPE#NASDAQ">VAPE</a>) will be used to establish the largest publicly listed BNB Chain digital asset treasury strategy in the world.</li>
<li>$BNB is the fourth largest cryptocurrency in the world, with $100B+ market cap, and provides the treasury with opportunities to generate income and rewards on the BNB Chain and Binance ecosystem, the world's #1 digital assets infrastructure by volume, with over 280 million users in over 180 countries.</li>
<li>The BNB treasury strategy will be led by incoming CEO <a href="https://www.linkedin.com/in/namdar/">David Namdar</a> (Co-founder of Galaxy Digital and Senior Partner at 10X Capital), incoming CIO <a href="https://www.linkedin.com/in/russell-read-38424263/">Russell Read</a> (former CIO of CalPERS and CIO of 10X Capital) and <a href="https://www.linkedin.com/in/saad-bachir-al-naja-69166756/">Saad Naja</a> (former director at Kraken and one of the executive board of directors of global retail brokerage firm <a href="https://www.exinity.com">Exinity</a>).</li>
<li><a href="https://10xcapital.com">10X Capital</a>, who also served as financial advisor to Nakamoto, will serve as the asset manager of the BNB treasury strategy,&nbsp;<a href="https://x.com/yzilabs/status/1943118544356675936">with the support of YZiLabs</a>.</li>
<li>Over 140 subscribers, led by institutional and crypto-native investors including YZi Labs, <a href="https://panteracapital.com">Pantera Capital</a>, <a href="https://arche.capital">Arche Capital</a>, <a href="https://www.gsr.io/">GSR</a>, <a href="https://borderlesscapital.io">Borderless</a>, <a href="https://www.arringtoncapital.com">Arrington</a> Capital, Blockchain.com, <a href="https://www.hypersphere.ventures">Hypersphere Capital</a>, Kenetic, <a href="https://dao5.com">dao5</a>, <a href="https://www.protocolventures.com">Protocol Ventures</a>, Reciprocal Ventures, <a href="https://www.g20.group">G-20 Group</a>, <a href="https://www.tpc.us">Three Point Capital</a>, Propel Horizon, <a href="https://www.exinity.com/">Exinity</a>, Winone, Nano Labs, and several other prominent investors including&nbsp;<a href="https://www.linkedin.com/in/olafcw/">Olaf Carlson Wee</a>, Rajeev Misra's family office and the founders of <a href="https://bitfury.com">BitFury</a>, participated in the offering.</li>
<li>The transaction is expected to close on or around July 31, 2025.</li>
</ul>

Offerings

VAPE

CEA Industries And 10X Capital, With YZi Labs Support, Announce $500M Private Placement

BCB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCBP#NASDAQ">BCBP</a>) reported quarterly earnings of $0.18 per share which met the analyst consensus estimate. This is a 28.57 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $25.178 million which beat the analyst consensus estimate of $24.325 million by 3.51 percent. This is a 23.39 percent increase over sales of $20.405 million the same period last year.

Earnings

Earnings Beats

BCBP

BCB Bancorp Q2 EPS $0.18, Inline, Sales $25.178M Beat $24.325M Estimate

JP Morgan analyst Matthew Boss maintains Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) with a Overweight and raises the price target from $154 to $156.

Price Target

Analyst Ratings

ROST

JP Morgan Maintains Overweight on Ross Stores, Raises Price Target to $156

Susquehanna analyst Bascome Majors maintains Saia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) with a Neutral and raises the price target from $275 to $340.

SAIA

Susquehanna Maintains Neutral on Saia, Raises Price Target to $340

Strong clinical interest and early procedures completed
Entered into distribution agreement with GlamMoon,&nbsp; a division of BeauCare Clinics Investment Co., Ltd. post-initial market clearance

APYX

Apyx Medical Launches Renuvion In China

JP Morgan analyst Matthew Boss maintains Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) with a Overweight and raises the price target from $280 to $338.

BURL

JP Morgan Maintains Overweight on Burlington Stores, Raises Price Target to $338

Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>) (the "Company" or "Upexi"), a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space, today announced it has entered into an equity line agreement with A.G.P./Alliance Global Partners enabling Upexi to sell up to $500 million of the Company's common stock at the Company's sole discretion, subject to certain restrictions and closing conditions. Any proceeds from the equity line, which included no commitment fee, will be used for general corporate purposes and to further the Company's Solana treasury strategy.
Allan Marshall, Upexi's Chief Executive Officer, stated, "The equity line gives Upexi additional means and flexibility to raise capital and increase its Solana position. The equity line was negotiated with zero fees and particularly friendly terms, and represents an attractive cost of capital. Upexi now has a multitude of tools to raise capital in the most cost-effective and accretive manner to build on its growing Solana treasury."

Contracts

Treasuries

UPXI

Upexi, Inc Enters Into $500M Equity Line Agreement With A.G.P. To Spur Growth Of Its Solana Treasury Strategy

Increases total holdings to 1,535,772 HYPE
Company to host investor webinar on Tuesday, July 29th at 2:00pm ET
LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPD#NASDAQ">HYPD</a>) ("Hyperion DeFi" or the "Company"), today announced that it has acquired an additional 108,594 HYPE tokens, expanding its total holdings to 1,535,772 HYPE purchased at an average price of $36.14 per token.
This latest purchase is in preparation of deploying HYPE into Kinetiq's iHYPE ("Institutional HYPE") pool, a gated smart contract environment that provides access to the iHYPE Liquid Staking Token (LST). iHYPE is available only for select institutional participants that complete KYB/AML verification and compliance onboarding.

HYPD

Hyperion Defi Acquires Additional 108,594 HYPE Tokens, Expanding Total Holdings To 1,535,772 HYPE Purchased At Average Price Of $36.14 Per Token

American Eagle Outfitters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated American Eagle Outfitters and provided 12-month price targets. The average target is $10.14, accompanied by a high estimate of $12.00 and a low estimate of $9.00. Experiencing a 10.19% decline, the current average is now lower than the previous average price target of $11.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1753704068_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of American Eagle Outfitters by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Maintains</td>
<td>Underweight</td>
<td>$9.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$10.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Simeon Siegel</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$11.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$9.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Adrienne Yih</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to American Eagle Outfitters. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American Eagle Outfitters compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of American Eagle Outfitters's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into American Eagle Outfitters's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/AEO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on American Eagle Outfitters analyst ratings.</a>
<h2>Unveiling the Story Behind American Eagle Outfitters</h2>
American Eagle Outfitters Inc is a specialty retailer. The company is engaged in the retail of apparel and accessories with company stores in the United States, Canada, Mexico, and Hong Kong. The Company leases all store premises, regional distribution facilities, some of its office space, and certain information technology and office equipment. American Eagle also has its online business. It operates in two segments: American Eagle and Aerie. The majority of its revenue comes from its primary brand, American Eagle, which offers an assortment of specialty apparel, accessories, and personal care products for women and men. Geographically, it generates the majority of its revenue from the United States.
<h3>American Eagle Outfitters's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Challenges: American Eagle Outfitters's revenue growth over 3M faced difficulties. As of 30 April, 2025, the company experienced a decline of approximately -4.74%. This indicates a decrease in top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: American Eagle Outfitters's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -5.96%, the company may face hurdles in effective cost management.
Return on Equity (ROE): American Eagle Outfitters's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -4.0%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): American Eagle Outfitters's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -1.71%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.2.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

7 Analysts Have This To Say About American Eagle Outfitters

Throughout the last three months, 4 analysts have evaluated First Citizens BancShares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $2125.0, with a high estimate of $2250.00 and a low estimate of $2050.00. Witnessing a positive shift, the current average has risen by 3.66% from the previous average price target of $2050.00.
<img src="https://www.benzinga.com/files/images/story/2025/1753704058_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of First Citizens BancShares by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stephen Scouten</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$2150.00</td>
<td>$2150.00</td>
</tr>
<tr>
<td>Benjamin Gerlinger</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$2050.00</td>
<td>$1900.00</td>
</tr>
<tr>
<td>Anthony Elian</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$2250.00</td>
<td>$2100.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Hold</td>
<td>$2050.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to First Citizens BancShares. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of First Citizens BancShares compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of First Citizens BancShares's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of First Citizens BancShares's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FCNCA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on First Citizens BancShares analyst ratings.</a>
<h2>Get to Know First Citizens BancShares Better</h2>
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.
<h3>First Citizens BancShares: A Financial Overview</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, First Citizens BancShares faced challenges, resulting in a decline of approximately -5.87% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 20.41%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.19%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.21%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: First Citizens BancShares's debt-to-equity ratio surpasses industry norms, standing at 1.79. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Analyst Ratings: What Are They?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FCNCA

Forecasting The Future: 4 Analyst Projections For First Citizens BancShares

During the last three months, 7 analysts shared their evaluations of Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>), revealing diverse outlooks from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Ultragenyx Pharmaceutical, presenting an average target of $61.14, a high estimate of $80.00, and a low estimate of $34.00. This current average has decreased by 3.26% from the previous average price target of $63.20. 
<img src="https://www.benzinga.com/files/images/story/2025/1753704047_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Ultragenyx Pharmaceutical among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Announces</td>
<td>Buy</td>
<td>$80.00</td>
<td>-</td>
</tr>
<tr>
<td>Laura Chico</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Jeffrey Hung</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Tiago Fauth</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Debjit Chattopadhyay</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$64.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Sami Corwin</td>
<td>William Blair</td>
<td>Announces</td>
<td>Outperform</td>
<td>$65.00</td>
<td>-</td>
</tr>
<tr>
<td>Jeffrey Hung</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Ultragenyx Pharmaceutical. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ultragenyx Pharmaceutical compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Ultragenyx Pharmaceutical's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Ultragenyx Pharmaceutical's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/RARE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Ultragenyx Pharmaceutical analyst ratings.</a>
<h2>Delving into Ultragenyx Pharmaceutical's Background</h2>
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
<h3>Breaking Down Ultragenyx Pharmaceutical's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Ultragenyx Pharmaceutical's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 27.99% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Ultragenyx Pharmaceutical's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -108.46%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Ultragenyx Pharmaceutical's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -75.63%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Ultragenyx Pharmaceutical's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -10.73%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.27.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RARE

Beyond The Numbers: 7 Analysts Discuss Ultragenyx Pharmaceutical Stock

In the latest quarter, 6 analysts provided ratings for Hain Celestial Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAIN#NASDAQ">HAIN</a>), showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Hain Celestial Group, presenting an average target of $2.63, a high estimate of $5.00, and a low estimate of $1.50. Highlighting a 40.5% decrease, the current average has fallen from the previous average price target of $4.42. 
<img src="https://www.benzinga.com/files/images/story/2025/1753704038_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Hain Celestial Group by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Baumgartner</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$2.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Michael Lavery</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$1.80</td>
<td>$2.00</td>
</tr>
<tr>
<td>John Baumgartner</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$3.00</td>
<td>$3.50</td>
</tr>
<tr>
<td>Andrew Lazar</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$2.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Anthony Vendetti</td>
<td>Maxim Group</td>
<td>Lowers</td>
<td>Buy</td>
<td>$5.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Matthew Smith</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$1.50</td>
<td>$4.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Hain Celestial Group. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Hain Celestial Group compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Hain Celestial Group's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Hain Celestial Group's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HAIN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Hain Celestial Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Delving into Hain Celestial Group's Background</h2>
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby &amp; kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
<h3>Hain Celestial Group: Delving into Financials</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Negative Revenue Trend: Examining Hain Celestial Group's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -10.95% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Hain Celestial Group's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -34.48%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Hain Celestial Group's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -17.93%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Hain Celestial Group's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -7.07%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 1.11, Hain Celestial Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HAIN

Demystifying Hain Celestial Group: Insights From 6 Analyst Reviews

Floor &amp; Decor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FND#NYSE">FND</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Floor &amp; Decor Hldgs, presenting an average target of $83.33, a high estimate of $100.00, and a low estimate of $70.00. Experiencing a 12.51% decline, the current average is now lower than the previous average price target of $95.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1753704028_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Floor &amp; Decor Hldgs among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Greg Melich</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$80.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Anthony Chukumba</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$75.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$70.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Seth Sigman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$78.00</td>
<td>$91.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$75.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>David Bellinger</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$70.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Steven Forbes</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$80.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>W. Andrew Carter</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$92.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Joseph Feldman</td>
<td>Telsey Advisory Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$115.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Floor &amp; Decor Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Floor &amp; Decor Hldgs compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Floor &amp; Decor Hldgs's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Floor &amp; Decor Hldgs's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FND/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Floor &amp; Decor Hldgs analyst ratings.</a>
<h2>Get to Know Floor &amp; Decor Hldgs Better</h2>
Floor &amp; Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.
<h3>Floor &amp; Decor Hldgs's Economic Impact: An Analysis</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Floor &amp; Decor Hldgs displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 5.78%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: Floor &amp; Decor Hldgs's net margin is impressive, surpassing industry averages. With a net margin of 4.21%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.23%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Floor &amp; Decor Hldgs's ROA stands out, surpassing industry averages. With an impressive ROA of 0.94%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.88, Floor &amp; Decor Hldgs adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Floor & Decor Hldgs Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)

JP Morgan analyst Samik Chatterjee maintains Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) with a Overweight and raises the price target from $190 to $200.

QCOM

JP Morgan Maintains Overweight on Qualcomm, Raises Price Target to $200

Analysts' ratings for Core &amp; Main (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNM#NYSE">CNM</a>) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $65.14, a high estimate of $70.00, and a low estimate of $56.00. This current average has increased by 7.03% from the previous average price target of $60.86. 
<img src="https://www.benzinga.com/files/images/story/2025/1753704018_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of Core &amp; Main among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jeffrey Stevenson</td>
<td>Loop Capital</td>
<td>Maintains</td>
<td>Hold</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Sam Reid</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$70.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$62.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Mike Dahl</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Jeffrey Stevenson</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Sam Reid</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Stephen Tusa</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$56.00</td>
<td>$54.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Core &amp; Main. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Core &amp; Main compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Core &amp; Main's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Core &amp; Main's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CNM/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Core &amp; Main analyst ratings.</a>
<h2>About Core &amp; Main</h2>
Core &amp; Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is principally generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.
<h3>Core &amp; Main: Financial Performance Dissected</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Core &amp; Main showcased positive performance, achieving a revenue growth rate of 9.76% as of 30 April, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Core &amp; Main's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 5.23%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 5.81%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Core &amp; Main's ROA stands out, surpassing industry averages. With an impressive ROA of 1.65%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 1.45, Core &amp; Main adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Core & Main: Insights From 7 Analyst Reviews

As the uncertainty surrounding Trump tariffs and other policy changes in Washington continues, middle-income Americans are accelerating their car-buying plans, a new survey reveals.
What Happened: A new survey by&nbsp;Santander Holdings USA&nbsp;shows that the majority of middle-income Americans are concerned about rising car prices and the impact of future price uncertainty. Despite these worries, three-quarters of the respondents believe&nbsp;they are on the right&nbsp;financial track,&nbsp;<a href="https://www.axios.com/2025/07/28/car-buyers-prices-tariffs-survey?ref=biztoc.com">reported</a>&nbsp;Axios on Monday.
&#8220;Our&nbsp;research finds consumers are taking&nbsp;proactive steps to secure what&nbsp;matters most, especially autos,&#8221; said&nbsp;Betty Jotanovic, president of auto&nbsp;relationships at Santander Consumer USA.
The survey also highlights the significance of vehicle access to families, with many consumers making proactive decisions to secure their transportation needs.
Consumers are keeping a close eye on how uncertainty around future prices might influence their spending decisions. In Q2, 55% said they were considering purchasing a car in the next year, up from 47% in Q1. Additionally, 18% accelerated major purchases due to price concerns, with 41% of those buying a car.
Despite rising prices, consumers appear more eager to make a move—half of potential buyers say they're now more likely to take out an auto loan, 48% are more inclined to buy a used vehicle, and 42% are more likely to complete a purchase within the next three months.
SEE ALSO:&nbsp;<a href="https://benzinga.com/markets/macro-economic-events/25/07/46651859/trumps-new-eu-trade-deal-labeled-bad-news-by-economists-as-dow-futures-spike-over-1" target="_blank" rel="noreferrer noopener">Trump&#8217;s New EU Trade Deal Labeled &#8216;Bad News&#8217; By Economists As Dow Futures Spike Over 150 Points</a>
Why It Matters: The surge in car-buying plans among middle-income Americans reflects the impact of the ongoing policy shifts in Washington. This trend is also evident in the used car market, where buyers are facing&nbsp;<a href="https://www.benzinga.com/personal-finance/management/25/07/46483841/a-used-car-buyer-is-baffled-by-prices-says-there-are-no-more-affordable-safe-and-reliable-starter-cars-with-less-than-100k-miles">sticker shock</a>&nbsp;and dealerships are&nbsp;<a href="https://www.benzinga.com/personal-finance/management/25/07/46370165/car-buyer-says-paying-cash-made-the-dealer-act-like-they-just-spoke-fluent-dolphin-theyre-not-dealerships-anymore-theyre-bankerships">reacting</a>&nbsp;to cash payments in unusual ways.
These changes are occurring against the backdrop of the Trump administration&#8217;s&nbsp;$550 billion <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46622277/trumps-trade-deal-with-japan-a-tax-on-americans-economist-says-not-remotely-optimistic-us-auto-companies-will-gain-as-toyota-and-honda-stocks-rally">trade deal with Japan</a>, which some experts argue is essentially a tax increase for American consumers. 
The American Automotive Policy Council, representing U.S. automakers like GM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Stellantis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>), has opposed a new trade deal that imposes a 25% tariff on U.S.-made vehicles from Canada and Mexico, while Japan faces only a 15% tariff, thus potentially raising vehicle prices in the U.S..
However, the U.S. Commerce Secretary&nbsp;<a href="https://www.benzinga.com/news/politics/25/07/46627767/commerce-secretary-howard-lutnick-dismisses-silly-concerns-of-us-automakers-over-japan-trade-deal-says-theyre-cool-with-it">Howard Lutnick</a>&nbsp;has stated that American auto CEOs are in favor of the new trade agreement.
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46549018/general-motors-delivers-q2-beat-braces-for-higher-tariff-pressures-ahead">General Motors Delivers Q2 Beat, Braces For Higher Tariff Pressures Ahead</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46549018/general-motors-delivers-q2-beat-braces-for-higher-tariff-pressures-ahead"> </a>

STLA

Trump Tariff Worries Drive Middle-Income Americans To Rush Car Buys: Report

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) with a Overweight and raises the price target from $66 to $72.

IDYA

JP Morgan Maintains Overweight on IDEAYA Biosciences, Raises Price Target to $72

Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) recent rally, in light of catalysts such as corporate earnings, the upcoming White House digital asset report, and the FOMC meeting <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46629919/why-are-public-companies-ammassing-eth-xrp-sol-bnb-instead-of-just-bitcoin">could lose momentum</a> once these events conclude.
According to a report by 10x Research, with no major triggers ahead and August–September historically weak months for crypto, Bitcoin may trade sideways or retrace unless new catalysts emerge.
The research notes that Bitcoin's latest price movements have been closely tied to short bursts of momentum rather than sustained trends, with each major rally triggered by events such as ETF approvals, Fed policy signals, or political developments. 
With corporate earnings, the White House digital asset report on July 30, and the Federal Open Market Committee (FOMC) meeting all concluding this week, the research suggests the market could enter a quieter phase.
Bitcoin recently dropped to $115,000 ahead of options expiry, a level that 10x had targeted in its June 24 report when it sold the $115,000 strike call for July. 
While 10x remains constructive on the asset in the longer term, its latest strategy involves a strangle trade selling the $105,000 put and $130,000 call for the August 29 expiry to generate yield during a potential consolidation phase.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46638394/congressional-subpoena-secret-doj-meetings-and-2m-in-bets-what-polymarket-traders-predict-for-ghislaine-maxwell">Congressional Subpoena, Secret DOJ Meetings&#8230;And $2M In Bets: What Polymarket Traders Predict For Ghislaine Maxwell</a>
Why It Matters: The White House digital asset report is expected to address a Strategic Bitcoin Reserve, regulatory frameworks, and systemic oversight.
10x Research cautions that a lack of clarity on the U.S. government's actual Bitcoin holdings and the timing of policy decisions could limit its market impact.
Reports suggest that the U.S. Marshals Service controls around 28,988 BTC, significantly below earlier estimates exceeding 200,000 BTC.
10x also highlights that Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) rally, driven primarily by treasury allocations from companies like Bitmine (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BMNR#AMEX">BMNR</a>) and Sharplink (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) rather than core network activity, could face similar risks if momentum slows. 
Ethereum's market cap and trading volumes have surged by over 50% in the past month, while fees and active addresses have only risen in single-digit percentages.
With August seasonality often resulting in lower volumes and reduced institutional participation, 10x warns that the Bitcoin market could become range-bound between $111,673 and $120,000. 
The research stresses that discipline and tighter stop-losses will be crucial for traders navigating the weeks ahead.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46637583/bitcoin-halving-cycles-no-longer-key-says-bitwises-matt-hougan">Bitcoin Halving Cycles? No Longer Key, Says Bitwise&#8217;s Matt Hougan</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

BMNR

SBET

Bitcoin May Turn Range-Bound Soon For These 3 Reasons: 10x Research

Calumet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMT#NASDAQ">CLMT</a>) ("Calumet" or the "Company") announced today that it has extended its Shreveport terminal asset financing arrangement with Stonebriar Commercial Finance LLC ("Stonebriar"). This transaction increases the assigned value of these terminal assets to $120 million and will provide $80 million of proceeds to Calumet, the difference between the new value of the assets and the remaining $40 million balance on the prior schedule. The previous sale leaseback agreement originally valued these assets at $70 million, which were scheduled to be repurchased in February 2027. This transaction carries a cost of capital of 10.75%, and net proceeds will be used to reduce Calumet's outstanding 11.00% Senior Notes due 2026 ("2026 Notes"). Further, Calumet has delivered a notice for a partial redemption of $80 million aggregate principal amount of its outstanding 2026 Notes at a redemption price of par, plus accrued and unpaid interest to, but not including, the redemption date of August 12, 2025.&nbsp; &nbsp;&nbsp;

Comments

Rave Restaurant Group

Notizie

Ultime notizie per Rave Restaurant Group (NASDAQ:RAVE) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO